NeurOp, Inc. is a clinical-stage biotechnology company developing medicines for CNS disorders including severe pain, catastrophic childhood epilepsies and subarachnoid hemorrhage.
Our Science
Our compounds are designed to target various subunits of N-methyl-D-aspartate (NMDA) receptors.
About Us
Our expertise in a critical signaling pathway in the central nervous system is leading to promising drug compounds.